Opportunity Information: Apply for RFA OD 22 026
The Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) is a National Institutes of Health (NIH) grant opportunity designed to help outstanding postdoctoral researchers move more quickly from mentored training into independent, faculty-level research careers, specifically in the area of tobacco regulatory science. The central goal is to build and sustain a strong pipeline of new, independent investigators whose work can directly inform how tobacco products are regulated in the United States, including how regulations are developed, assessed, and refined over time. The research emphasis is on evidence that can support oversight of tobacco product manufacturing, distribution, and marketing, meaning projects should be aligned with questions relevant to real-world regulatory decisions rather than purely theoretical or exploratory topics.
This mechanism follows the classic NIH "Pathway to Independence" structure, which supports a two-stage career transition. The first stage (K99) supports a mentored postdoctoral period where the candidate deepens their expertise, publishes, builds a focused research niche, and completes targeted career development activities under the guidance of established mentors. The second stage (R00) supports the transition to an independent, tenure-track or equivalent position, providing resources for the candidate to launch their own research program as an independent investigator. The intent is that a strong K99 phase sets up a credible, competitive move into an independent role, and the R00 phase then helps establish momentum through early independent productivity, team-building, and the generation of results needed to compete for larger, long-term research awards.
A key feature of this specific announcement is that an independent clinical trial is required. In practical terms, applicants should expect that the proposed research will include a clinical trial component where the awardee, as the investigator, is responsible for planning and carrying out the trial. This requirement signals that NIH expects projects to produce high-quality human-subject evidence that can be meaningful to tobacco regulation, such as trials that evaluate behavioral, communication, product-related, or other interventions relevant to tobacco product use and regulatory policy. Because clinical trial responsibilities come with added expectations around oversight, safety monitoring, data integrity, and compliance, applicants should be prepared to demonstrate the training, mentorship, and institutional support needed to execute a trial successfully.
Eligibility for applicant organizations is broad across U.S.-based entities. Eligible applicants include various levels of government (state, county, city or township, and special district governments), federally recognized Native American tribal governments, tribal organizations that are not federally recognized, public housing authorities/Indian housing authorities, and a wide range of higher education institutions (public/state-controlled and private). Nonprofit organizations are eligible whether or not they hold 501(c)(3) status, and for-profit organizations (other than small businesses) and small businesses are also listed as eligible. The announcement also explicitly calls out additional categories of eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, the opportunity places clear restrictions on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are not eligible, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In other words, the applicant organization and the work supported by the award must be situated within allowable U.S.-based institutional structures without foreign components under NIH definitions.
From an administrative standpoint, this is a discretionary grant (FundingInstrumentType: Grant) in the health funding category, associated with CFDA number 93.077, and sponsored by the National Institutes of Health. The funding opportunity title is listed exactly as "Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)," and the funding opportunity number is RFA-OD-22-026. The original closing date provided is 2025-03-12. While the source data does not specify an award ceiling or the expected number of awards, the purpose statement makes clear that NIH is using this mechanism to cultivate a cohort of early-career researchers positioned to become long-term leaders in tobacco regulatory research.
Overall, this opportunity is best understood as a career-accelerating, mentored-to-independent bridge award for postdoctoral researchers with research and/or clinical doctorates who are ready to propose clinically oriented tobacco regulatory studies with direct relevance to FDA/NIH regulatory science priorities. It is structured to reward strong candidates who have clear potential for independence, a feasible plan to run an independent clinical trial, and a career development strategy that culminates in securing an independent faculty-equivalent position and establishing a durable research program in tobacco regulation.Apply for RFA OD 22 026
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.077.
- This funding opportunity was created on 2022-11-10.
- Applicants must submit their applications by 2025-03-12. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00)?
It is a National Institutes of Health (NIH) grant opportunity intended to help outstanding postdoctoral researchers transition more quickly from mentored training into independent, faculty-level research careers. This specific award focuses on tobacco regulatory science, with the goal of building a pipeline of independent investigators whose research can directly inform how tobacco products are regulated in the United States.
What is the main goal of this funding opportunity?
The central goal is to build and sustain a strong pipeline of new, independent investigators conducting tobacco regulatory research that can inform real-world regulatory decision-making. The emphasis is on evidence that supports oversight of tobacco product manufacturing, distribution, and marketing, including how regulations are developed, assessed, and refined over time.
What research areas or topics does this award emphasize?
The research emphasis is on tobacco regulatory science that can support U.S. regulation of tobacco products. Projects should align with questions relevant to real-world regulatory decisions (for example, questions that could inform regulatory policy, oversight, or evaluation) rather than being purely theoretical or exploratory.
How is the K99/R00 award structured?
This mechanism uses a two-stage career transition structure:
- K99 phase: A mentored postdoctoral period where the candidate deepens expertise, publishes, develops a focused research niche, and completes targeted career development activities under established mentors.
- R00 phase: A transition to an independent, tenure-track or equivalent position, with support to launch an independent research program and build early independent productivity and momentum.
What is the purpose of the K99 (mentored) phase?
The K99 phase is designed to help the candidate strengthen their scientific foundation and trajectory toward independence by building expertise, producing publications, shaping a distinct research niche, and completing focused career development activities with mentor support.
What is the purpose of the R00 (independent) phase?
The R00 phase supports the candidate after they secure an independent, tenure-track or equivalent position. It is intended to help launch and establish the candidate's independent research program, including early results and team-building that can position the investigator to compete for larger, long-term research awards.
Does this specific K99/R00 opportunity require a clinical trial?
Yes. A key feature of this announcement is that an independent clinical trial is required. The proposed research is expected to include a clinical trial component for which the awardee, as the investigator, is responsible for planning and carrying out the trial.
What does "independent clinical trial required" mean in practical terms?
It means the applicant should expect to propose a study that includes a clinical trial, and the awardee is responsible for trial planning and execution. This implies added expectations around oversight, safety monitoring, data integrity, and compliance, and applicants should be prepared to show appropriate training, mentorship, and institutional support to conduct the trial successfully.
What kinds of clinical trials are implied as relevant for this opportunity?
The description indicates trials that generate high-quality human-subject evidence meaningful to tobacco regulation, including trials evaluating behavioral, communication, product-related, or other interventions relevant to tobacco product use and regulatory policy.
Who is this opportunity designed for?
It is designed for outstanding postdoctoral researchers who are ready to move from mentored training to independent research careers in tobacco regulatory science. The opportunity is positioned as a career-accelerating bridge for postdoctoral researchers with research and/or clinical doctorates who can propose clinically oriented regulatory studies and a credible plan for independence.
What types of applicant organizations are eligible?
Eligibility for applicant organizations is broad across U.S.-based entities, including:
- State, county, city or township governments, and special district governments
- Federally recognized Native American tribal governments
- Tribal organizations that are not federally recognized
- Public housing authorities/Indian housing authorities
- Higher education institutions (public/state-controlled and private)
- Nonprofit organizations (with or without 501(c)(3) status)
- For-profit organizations (other than small businesses) and small businesses
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISI)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Faith-based or community-based organizations
- Eligible federal agencies
- Regional organizations
- U.S. territories or possessions
Are foreign (non-U.S.) organizations allowed to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
Can a U.S. organization include a foreign or non-domestic component in the project?
No. Non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. The applicant organization and the work supported by the award must be situated within allowable U.S.-based institutional structures without foreign components under NIH definitions.
Which agency sponsors this opportunity?
The opportunity is sponsored by the National Institutes of Health (NIH).
What is the funding instrument type?
This is a discretionary grant (FundingInstrumentType: Grant).
What is the funding category?
The funding category is health.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.077.
What is the official funding opportunity title?
The title is "Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)."
What is the funding opportunity number?
The funding opportunity number is RFA-OD-22-026.
What is the closing date listed for this opportunity?
The original closing date provided is 2025-03-12.
Does the provided information include an award ceiling or the expected number of awards?
No. The source information does not specify an award ceiling or the expected number of awards.
How does NIH describe the intended impact of this mechanism?
NIH is using this mechanism to cultivate a cohort of early-career researchers positioned to become long-term leaders in tobacco regulatory research, with work that can directly inform regulation of tobacco products in the United States.
What kind of research positioning is expected from applicants?
Applicants are expected to propose clinically oriented tobacco regulatory studies with direct relevance to regulatory science priorities, and to present a career development strategy that supports a credible transition to an independent faculty-equivalent position and a durable research program.
What additional expectations come with the clinical trial requirement?
Because clinical trial responsibilities typically involve oversight, safety monitoring, data integrity, and compliance obligations, applicants should be prepared to demonstrate the training, mentorship, and institutional support needed to execute an independent clinical trial successfully.
Browse more opportunities from the same category: Health
Next opportunity: NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
Previous opportunity: Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 22 026
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 22 026) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) Apply for RFA OD 22 023 Funding Number: RFA OD 22 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limpopo Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 LIMPOPO Funding Number: RFI 674 23 LIMPOPO Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| Free State Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 FREESTATE Funding Number: RFI 674 23 FREESTATE Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| North West Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 NORTHWEST Funding Number: RFI 674 23 NORTHWEST Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) Apply for RFA AI 22 069 Funding Number: RFA AI 22 069 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Apply for PAR 24 022 Funding Number: PAR 24 022 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for PAR 23 025 Funding Number: PAR 23 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for PAR 23 026 Funding Number: PAR 23 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32) Apply for PAR 23 030 Funding Number: PAR 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 067 Funding Number: RFA AI 22 067 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) Apply for PAR 23 054 Funding Number: PAR 23 054 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) Apply for PAR 23 053 Funding Number: PAR 23 053 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mozambique Local Tuberculosis Response II Apply for 72065623 RFI TBCONTROL Funding Number: 72065623 RFI TBCONTROL Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) Apply for RFA MH 23 310 Funding Number: RFA MH 23 310 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mozambique Local Tuberculosis Response II Apply for 720656 RFI TBCONTROL Funding Number: 720656 RFI TBCONTROL Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Apply for PAR 22 256 Funding Number: PAR 22 256 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 23 065 Funding Number: PAR 23 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 23 003 Funding Number: RFA RM 23 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 002 Funding Number: RFA OD 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 23 036 Funding Number: PAR 23 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 22 026", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.